Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02924207 · ClinicalTrials.gov registry record · NA
Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes
A NA study, sponsored by St Elizabeth Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02924207: Completed NA study, sponsored by St Elizabeth Healthcare.
NCT02924207 is a NA study that has completed, run by St Elizabeth Healthcare. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02924207, a NA study, has completed, sponsored by St Elizabeth Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint will measure change in hemoglobin A1c. Secondary endpoints will examine cost of therapy and patient satisfaction with therapy. Study hypothesis is that use of the PATH decision tool will produce greater reduction overall in measurements of hemoglobin A1c in patients who participate and follow the PATH decision tool than patients who elect not to follow the PATH decision tool. PATH decision tool will provide more cost effective solutions for management of diabetic medication than current methods.
Primary Outcome
change in hemoglobin A1c from baseline
Interventions
- OTHER PATH electronic decision support tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02924207 record still lists
NCT02924207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which PATH electronic decision support tool is the first listed.
NCT02924207 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02924207 about?
NCT02924207 is a clinical study titled "Electronic Decision Support for Intervention in Poorly Controlled Type 2 Diabetes". To determine the impact of an electronic decision support tool on physician decision making and patient outcomes for the treatment of poorly controlled diabetes mellitus. Primary endpoint will measure change in hemoglobin A1c. Secondary endpoints will examine cost of therapy and patient satisfaction...
What is the current status of trial NCT02924207?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2016-09. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02924207?
The interventions under investigation include: PATH electronic decision support tool (OTHER).
Who is sponsoring clinical trial NCT02924207?
This trial is sponsored by St Elizabeth Healthcare, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02924207's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia